A Prospective Safety Surveillance Study of Fentanyl Iontophoretic Transdermal System (40 Mcg)

DRUG: fentanyl iontophoretic transdermal system (40mcg) No Placebo
DRUG: IV PCA with standard of care opioid analgesia

TERMINATED

Status

218

Enrollment

INDUSTRY

Sponsor class

Stopped Study was terminated at the request of the company due to the recall of marketed product in Europe.

Conditions

Alza Corporation, DE, USA